MAPT and Alzheimer disease: Human and animal model data suggest a causal upstream role for amyloid/tau pathways in AD pathogenesis; and although β-amyloidosis alone may be insufficient to cause cognitive deterioration directly, it is likely to trigger a cascade of downstream pathologic changes that lead to cognitive decline [20,21,22].